Adalimumab-adbm - NDC Database

10 records found

Page:1

0597-0545 Oct 01, 2023
Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.

0597-0555 Oct 01, 2023
Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.

0597-0565 Apr 30, 2024
Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.

0597-0575 Apr 30, 2024
Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.

0597-0585 Oct 01, 2023
Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.

0597-0595 Oct 01, 2023
Adalimumab-adbmAdalimumab-adbm Kit by Boehringer Ingelheim Pharmaceuticals, Inc.

82009-144 Apr 30, 2024
Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC

82009-146 Apr 30, 2024
Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC

82009-148 Apr 30, 2024
Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC

82009-150 Apr 30, 2024
Adalimumab-adbmAdalimumab-adbm Kit by Quallent Pharmaceuticals Health LLC

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.